Healthbeat - Your Source for Daily Health Trends and Medical News

STAT+: Pharmalittle: We’re reading about FDA losing key personnel, a ‘colossal’ Pfizer tax dodge, and more

Both deputy directors at the key FDA center that oversees regulation of cancer drugs plan on leaving the agency

C3TI Areas of Interest

C3TI's areas of interest span drug development programs, therapeutic areas, and disciplines. Learn more.

FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis

The FDA granted marketing authorization of the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription and performed entirely at home.

HHS Probes Major Medical School; Scientists Quitting the U.S.; Long COVID Studies Axed

(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.

Pfizer accused of major tax-dodging scheme

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning.

The protective power of gender-affirming hormones, part two

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The Department of Health and Human Services is cutting 20,000 employees.

Notifications on Data Integrity

FDA notifications for industry on data integrity.

FDA to pharmaceutical companies: Certain studies conducted by Raptim Research Pvt. Ltd. are unacceptable

FDA has identified significant data integrity and study conduct concerns with bioequivalence and bioavailability studies conducted by Raptim Research Pvt. Ltd.

STAT+: Eli Lilly’s Alzheimer’s drug gets thumbs down from European regulators

Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.

Respiratory diseases on the rise: A growing concern for India

Rakesh Jain highlights the surge in respiratory-related hospitalisations, the financial burden on patients, and the urgent need for preventive measures amid worsening air quality and seasonal spikes

All News